Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Cefepime in an In Vitro Infection Model

We previously demonstrated that for tazobactam administered in combination with ceftolozane, the pharmacokinetic-pharmacodynamic (PK-PD) index that best described tazobactam efficacy was the percentage of the dosing interval that tazobactam concentrations were above a threshold (%T>threshold). Us...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Antimicrob Agents Chemother
Auteurs principaux: VanScoy, Brian D., Tenero, David, Turner, Simon, Livermore, David M., McCauley, Jennifer, Conde, Haley, Bhavnani, Sujata M., Rubino, Christopher M., Ambrose, Paul G.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2017
Sujets:
Pharmacology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5700300/
https://ncbi.nlm.nih.gov/pubmed/28947475
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01052-17
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires